The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial (original) (raw)

Low dose of ROSuvastatin in combination with EZEtimibe effectively and permanently reduce low density lipoprotein cholesterol concentration independently of timing of administration (ROSEZE): A randomized, crossover study — preliminary results

Michał Kasprzak

Cardiology Journal, 2021

View PDFchevron_right

Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia

Stella Daskalopoulou

Current Medical Research and Opinion, 2006

View PDFchevron_right

The combination of Ezetimibe and Statin: a new treatment for hypercholesterolemia

Luca Bettari, Savina Nodari

Heart International, 2009

View PDFchevron_right

Efficacy and Safety of Ezetimibe Coadministered With Simvastatin in Patients With Primary Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Trial

Benny Kerzner

Mayo Clinic Proceedings, 2004

View PDFchevron_right

Efficacy and Safety of Ezetimibe Added to Atorvastatin Versus Atorvastatin Uptitration or Switching to Rosuvastatin in Patients With Primary Hypercholesterolemia

Philippe Brudi

The American Journal of Cardiology, 2013

View PDFchevron_right

Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter, Randomized Trial

stevin zung

Current Therapeutic Research-clinical and Experimental, 2020

View PDFchevron_right

Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers

Kyun-Seop Bae

Drug design, development and therapy, 2018

View PDFchevron_right

Safety and Efficacy of Ezetimibe/Simvastatin Combination Versus Atorvastatin Alone in Adults ≥65 Years of Age With Hypercholesterolemia and With or at Moderately High/High Risk for Coronary Heart Disease (the VYTELD Study)

Franklin Zieve

The American Journal of Cardiology, 2010

View PDFchevron_right

Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia A Prospective, Randomized, Double-Blind Trial

Steven Sun

2011

View PDFchevron_right

Efficacy and Safety of Ezetimibe Added on to Atorvastatin (20 mg) Versus Uptitration of Atorvastatin (to 40 mg) in Hypercholesterolemic Patients at Moderately High Risk for Coronary Heart Disease † † Conflicts of interest: Dr. Conard served as a consultant and advisor for Merck & Company and Merc...

Scott Conard

Amer J Cardiol, 2008

View PDFchevron_right

Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights

SAra SAlah

Drug Design, Development and Therapy

View PDFchevron_right

Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups

Ali Raza

American Journal of Cardiology, 2003

View PDFchevron_right

Combination therapy in cholesterol reduction: focus on ezetimibe and statins

L. Grigore

Vascular health and risk management, 2008

View PDFchevron_right

Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study

Mike Palmer

Atherosclerosis, 2014

View PDFchevron_right

Efficacy and Safety of Ezetimibe Added on to Atorvastatin (20 mg) Versus Uptitration of Atorvastatin (to 40 mg) in Hypercholesterolemic Patients at Moderately High Risk for Coronary Heart Disease

Mary Hanson

The American Journal of Cardiology, 2008

View PDFchevron_right

Efficacy and Safety of Ezetimibe Added on to Atorvastatin (40 mg) Compared With Uptitration of Atorvastatin (to 80 mg) in Hypercholesterolemic Patients at High Risk of Coronary Heart Disease

Scott Conard

American Journal of Cardiology, 2008

View PDFchevron_right

Pharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjects

Hyungmi An

Drug Design, Development and Therapy, 2017

View PDFchevron_right

Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial

Ali Raza

American Heart Journal, 2004

View PDFchevron_right

Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia

Suresh N

Journal of The American College of Cardiology, 2002

View PDFchevron_right

Efficacy and Safety of Ezetimibe Coadministered With Atorvastatin or Simvastatin in Patients With Homozygous Familial Hypercholesterolemia

Daniel Gaudet

Circulation, 2002

View PDFchevron_right

Efficacy and safety of rosuvastatin 40mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: Results of the POLARIS study

Robert Rosenson

Atherosclerosis, 2007

View PDFchevron_right